Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2α during inflammatory conditions

Journal of Immunology

Volumn 183, Issue 8, 2009, Pages 5013-5022

  Sugita, Sunao ^a   Horie, Shintaro ^a   Nakamura, Orie ^b   Maruyama, Kazuichi ^c   Takase, Hiroshi ^a   Usui, Yoshihiko ^d   Takeuchi, Masaru ^d   Ishidoh, Kazumi ^e   Koike, Masato ^f   Uchiyama, Yasuo ^f   Peters, Christoph ^g   Yamamoto, Yoshimi ^h   Mochizuki, Manabu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

^e TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^f JUNTENDO UNIVERSITY   (Japan)

^g UNIVERSITY OF FREIBURG   (Germany)

^h YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN L; CYTOTOXIC T LYMPHOCYTE ANTIGEN 2ALPHA; GAMMA INTERFERON; LYMPHOCYTE ANTIGEN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE UVEITIS; BYSTANDER EFFECT; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EYE INFLAMMATION; IMMUNOMODULATION; KNOCKOUT MOUSE; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PHENOTYPE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; UPREGULATION; UVEITIS;

ANIMALS; ANTIGENS, DIFFERENTIATION; CATHEPSIN L; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; EYE; EYE PROTEINS; FORKHEAD TRANSCRIPTION FACTORS; IMMUNE TOLERANCE; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RETINAL PIGMENT EPITHELIUM; RETINOL-BINDING PROTEINS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; UVEITIS;

EID: 77954136126     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901623     Document Type: Article

References (46)

1. Caspi, R. R. 1992. Immunogenetic aspects of clinical and experimental uveitis. Reg. Immunol. 4: 321-330.
2. Caspi, R. R. 1999. Immune mechanisms in uveitis. Springer Semin. Immunopathol. 21: 113-124.
3. Dullforce, P. A., G. W. Seitz, K. L. Garman, J. A. Michael, S. M. Crespo, R. J. Fleischman, S. R. Planck, D. C. Parker, and J. T. Rosenbaum. 2006. Antigen- specific accumulation of naive, memory and effector CD4 T cells during anterior uveitis monitored by intravital microscopy. Cell. Immunol. 239: 49-60.
4. Peng, Y., H. Shao, Y. Ke, P. Zhang, G. Han, H. J. Kaplan, and D. Sun. 2007. Minimally activated CD8 autoreactive T cells specific for IRBP express a high level of Foxp3 and are functionally suppressive. Invest. Ophthalmol. Vis. Sci. 48: 2178-2184.
5. low T cells in experimental autoimmune uveitis (EAU). J. Neuroimmunol. 183: 81-88.
6. Ke, Y., G. Jiang, D. Sun, H. J. Kaplan, and H. Shao. 2008. Ocular regulatory T cells distinguish monophasic from recurrent autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 49: 3999-4007.
7. Yamamoto, Y., M. Kurata, S. Watabe, R. Murakami, and S. Y. Takahashi. 2002. Novel cysteine proteinase inhibitors homologous to the proregions of cysteine proteinases. Curr. Protein Pept. Sci. 3: 231-238.
8. Kurata, M., M. Hirata, S. Watabe, M. Miyake, S. Y. Takahashi, and Y. Yamamoto. 2003. Expression, purification, and inhibitory activities of mouse cytotoxic T-lymphocyte antigen-2α. Protein Expression Purif. 32: 119-125.
9. Delaria, K., L. Fiorentino, L. Wallace, P. Tamburini, E. Brownell, and D. Muller. 1994. Inhibition of cathepsin L-like cysteine proteases by cytotoxic T-lymphocyte antigen-2β. J. Biol. Chem. 269: 25172-25177.
10. Felbor, U., L. Dreier, R. A. Bryant, H. L. Ploegh, B. R. Olsen, and W. Mothes. 2000. Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J. 19: 1187-1194. (Pubitemid 30151015)
11. Lombardi, G., D. Burzyn, J. Mundiñano, P. Berguer, P. Bekinschtein, H. Costa, L. F. Castillo, A. Goldman, R. Meiss, I. Piazzon, and I. Nepomnaschy. 2005. Cathepsin-L influences the expression of extracellular matrix in lymphoid organs and plays a role in the regulation of thymic output and of peripheral T cell number. J. Immunol. 174: 7022-7032.
12. Maehr, R., J. D. Mintern, A. E. Herman, A. M. Lennon-Dumenil, D. Mathis, C. Benoist, and H. L. Ploegh. 2005. Cathepsin L is essential for onset of autoimmune diabetes in NOD mice. J. Clin. Invest. 115: 2934-2943.
13. Sugita, S., S. Horie, O. Nakamura, Y. Futagami, H. Takase, H. Keino, H. Aburatani, N. Katunuma, K. Ishidoh, Y. Yamamoto, and M. Mochizuki. 2008. Retinal pigment epithelium-derived CTLA-2α induces TGFβ-producing T regulatory cells. J. Immunol. 181: 7525-7536.
14. Midorikawa, Y., S. Tsutsumi, H. Taniguchi, M. Ishii, Y. Kobune, T. Kodama, M. Makuuchi, and H. Aburatani. 2002. Identification of genes associated with dedifferentiation of hepatocellular carcinoma with expression profiling analysis. Jpn. J. Cancer Res. 93: 636-643.
15. Koike, M., M. Shibata, Y. Ohsawa, H. Nakanishi, T. Koga, S. Kametaka, S. Waguri, T. Momoi, E. Kominami, C. Peters, et al. 2003. Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice. Mol. Cell. Neurosci. 22: 146-161.
16. Sugita, S., and J. W. Streilein. 2003. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 198: 161-171.
17. + iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation. J. Immunol. 172: 4184-4194.
18. + T cells. J. Immunol. 176: 118-127.
19. Sugita, S., Y. Futagami, S. B. Smith, H. Naggar, and M. Mochizuki. 2006. Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor β. Exp. Eye Res. 83: 1459-1471.
20. + regulatory T cells. Invest. Ophthalmol. Vis. Sci. 47: 5376-5384.
21. Futagami, Y., S. Sugita, J. Vega, K. Ishida, H. Takase, K. Maruyama, H. Aburatani, and M. Mochizuki. 2007. Role of thrombospondin-1 in T cell response to ocular pigment epithelial cells. J. Immunol. 178: 6994-7005.
22. Avichezer, D., P. B. Silver, C. C. Chan, B. Wiggert, and R. R. Caspi. 2000. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype. Invest. Ophthalmol. Vis. Sci. 41: 127-131.
23. Thurau, S. R., C. C. Chan, R. B. Nussenblatt, and R. R. Caspi. 1997. Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals. Clin. Exp. Immunol. 109: 370-376.
24. Ruscetti, F., L. Varesio, A. Ochoa, and J. Ortaldo. 1993. Pleiotropic effects of transforming growth factor-β on cells of the immune system. Ann. NY Acad. Sci. 685: 488-500.
25. Kingsley, D. M. 1994. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8: 133-146. (Pubitemid 24044338)
26. + regulatory T cell activity in both humans and mice. J. Immunol. 172: 834-842.
27. + T cell subsets. J. Leukocyte Biol. 82: 335-346.
28. Bluestone, J. A., and A. K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3: 253-257.
29. Weiner, H. L. 2001. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol. Rev. 182: 207-214.
30. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
31. Beissert, S., A. Schwarz, and T. Schwarz. 2006. Regulatory T cells. J. Invest. Dermatol. 126: 15-24.
32. Fontenot, J. D., J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202: 901-906.
33. + regulatory T cells. Nat. Immunol. 4: 330-336.
34. Bennett, C. L., M. E. Brunkow, F. Ramsdell, K. C. O'Briant, Q. Zhu, R. L. Fuleihan, A. O. Shigeoka, H. D. Ochs, and P. F. Chance. 2001. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome. Immunogenetics 53: 435-439.
35. Tivol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3: 541-547.
36. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
37. + T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172: 5149-5153.
38. + T cells. J. Immunol. 173: 6526-6531.
39. Li, M. O., Y. Y. Wan, S. Sanjabi, A. K. Robertson, and R. A. Flavell. 2006. Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol. 24: 99-146.
40. +1 null mouse phenotype. Proc. Natl. Acad. Sci. USA 90: 9944-9948.
41. Lucas, P. J., S. J. Kim, S. J. Melby, and R. E. Gress. 2000. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor βII receptor. J. Exp. Med. 191: 1187-1196.
42. Gorelik, L., and R. A. Flavell. 2000. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12: 171-181. (Pubitemid 30398631)
43. Yang, X., J. J. Letterio, R. J. Lechleider, L. Chen, R. Hayman, H. Gu, A. B. Roberts, and C. Deng. 1999. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J. 18: 1280-1291.
44. + T cells induced by iris pigment epithelial cells display regulatory phenotype and acquire regulatory functions. Exp. Eye Res. 85: 626-636.
45. Tamai, M., C. Yokoo, M. Murata, K. Oguma, K. Sota, E. Sato, and Y. Kanaoka. 1987. Efficient synthetic method for ethyl+-(2S,3S)-3-[(S)-3-methyl-1- (3-methylbutylcarbamoyl) butylcarbamoyl]-2-oxiranecarb oxylate (EST), a new inhibitor of cysteine proteinases. Chem. Pharm. Bull. 35: 1098-1104.
46. Urbich, C., C. Heeschen, A. Aicher, K. Sasaki, T. Bruhl, M. R. Farhadi, P. Vajkoczy, W. K. Hofmann, C. Peters, L. A. Pennacchio, et al. 2005. Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat. Med. 11: 206-213.